Home

Pentokey Organy (india) Ltd PE Ratio

Image

Pentokey Organy (India) Ltd

NSE: PENTOKEYORGANY

PE

119.3

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Pentokey Organy (India) Ltd is 119.3 as of 15 Jan 14:23 PM .
  • The P/E Ratio of Pentokey Organy (India) Ltd changed from 8.2 on March 2023 to 40.3 on March 2024 . This represents a CAGR of 121.69% over 2 years.
  • The Latest Trading Price of Pentokey Organy (India) Ltd is ₹ 45.33 as of 15 Jan 13:52 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Pentokey Organy (India) Ltd

No data available

Company Fundamentals for Pentokey Organy (India) Ltd

Image

Pentokey Organy (India) Ltd

NSE: PENTOKEYORGANY

Share Price

₹ 45.33

0.00 (0.00%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Pentokey Organy (India) Ltd

1M

1Y

3Y

5Y

Monitoring Pentokey Organy (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 202545.33
13 Jan 202543.78
10 Jan 202548.4
09 Jan 202547.69
08 Jan 202548
07 Jan 202545.73
06 Jan 202546.16
03 Jan 202550.61
02 Jan 202548.89
01 Jan 202548.99

SWOT Analysis Of Pentokey Organy (India) Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Pentokey Organy (India) Ltd

Asset Value vs Market Value of Pentokey Organy (India) Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Pentokey Organy (India) Ltd28.42
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Pentokey Organy (India) Ltd Explained

``

28.42

Market cap

0

Earnings

119.3X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Pentokey Organy (India) Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Pentokey Organy (India) Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Pentokey Organy (India) Ltd

No data available

* All values are in %

About Pentokey Organy (India) Ltd

  • Pentokey Organy (India) Ltd was incorporated on November 26, 1986.
  • The Company is engaged in the trading of Pharmaceutical products such as Acetic Acid, Ethyl Acetate and Acetaldehyde.
  • Ethyl Acetate is preferred by customers in all markets as it is fast replacing the petroleum-based solvents such as Toluene, MEK (Methyl Ethyl Ketone), MIBK (Methyl Iso Butyl Ketone) etc. In 2012-13, the production of intermediate product namely Acetic Acid was not competitive due to market prices.
  • Company therefore purchased the Acetic Acid from market instead of producing the same from Ethanol or Acetaldehyde.
  • As a result of this, production of Acetaldehyde, which is an intermediate product for Acetic Acid, was low.

Pentokey Organy (India) Ltd News Hub

Pentokey Organy (India) AGM scheduled

Pentokey Organy (India) announced that the Annual General Meeting (AGM) of the company will be held

Read more

2024-08-12 00:00:00

Pentokey Organy (India) standalone net profit declines 88.37% in the June 2024 quarter

Net profit of Pentokey Organy (India) declined 88.37% to Rs 0.05 crore in the quarter ended June 202

Read more

2024-08-12 00:00:00

Pentokey Organy (India) to declare Quarterly Result

Pentokey Organy (India) will hold a meeting of the Board of Directors of the Company on 10 August 20

Read more

2024-08-07 00:00:00

Pentokey Organy (India) standalone net profit declines 69.44% in the September 2024 quarter

Net profit of Pentokey Organy (India) declined 69.44% to Rs 0.11 crore in the quarter ended Septembe

Read more

2024-11-11 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Pentokey Organy (India) Ltd

What is the current PE Ratio of Pentokey Organy (India) Ltd?

The Current PE Ratio of Pentokey Organy (India) Ltd is 119.29 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Pentokey Organy (India) Ltd last year?

The PE Ratio of Pentokey Organy (India) Ltd was 8.2 last year, now the PE ratio is 119.29, showing a year-on-year growth of 1354.8%.

What does the PE Ratio of Pentokey Organy (India) Ltd indicate about its stock?

The PE Ratio of Pentokey Organy (India) Ltd is 119.29. This ratio indicates that investors are willing to pay 119.29 times the earnings per share for each share of Pentokey Organy (India) Ltd.

What is the PE Ratio Growth of Pentokey Organy (India) Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Pentokey Organy (India) Ltd grew by 1354.8% whereas, the EPS ratio grew by 142.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions